These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16370474)

  • 1. [Treatment of erysipelas in Germany and Austria--results of a survey in German and Austrian dermatological clinics].
    Brennecke S; Hartmann M; Schöfer H; Rasokat H; Tschachler E; Brockmeyer NH
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):263-70. PubMed ID: 16370474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Penicillin G and erysipelas--still being used?].
    Graninger W
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):245-6. PubMed ID: 16370471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Management of erysipelas in French hospitals: a post-consensus conference study].
    Bernard P; Christmann D; Morel M
    Ann Dermatol Venereol; 2005 Mar; 132(3):213-7. PubMed ID: 15924042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erysipelas. Retrospective study of 647 patients].
    Zaraa I; Zeglaoui F; Zouari B; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2004 Nov; 82(11):990-5. PubMed ID: 15822466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of epidemiology, clinical features and management of erysipelas.
    Krasagakis K; Valachis A; Maniatakis P; Krüger-Krasagakis S; Samonis G; Tosca AD
    Int J Dermatol; 2010 Sep; 49(9):1012-7. PubMed ID: 20931671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.
    Ferreira A; Bolland MJ; Thomas MG
    Infection; 2016 Oct; 44(5):607-15. PubMed ID: 27085865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology, clinical features, and evolution of Erysipelas in the Marrakech region (100 cases)].
    Amal S; Houass S; Laissaoui K; Moufid K; Trabelsi M
    Med Mal Infect; 2004 Apr; 34(4):171-6. PubMed ID: 15619888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic usage in community-acquired pneumonia: results of a survey in 288 departments of internal medicine in German hospitals.
    Kappstein I; Daschner FD
    Infection; 1991; 19(5):301-4. PubMed ID: 1800367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.
    Krasagakis K; Samonis G; Maniatakis P; Georgala S; Tosca A
    Dermatology; 2006; 212(1):31-5. PubMed ID: 16319471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic usage for initial empirical treatment of infections in hospitalized patients in West Germany.
    Knothe H
    Infection; 1991; 19(3):127-30. PubMed ID: 1889863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillin as a therapeutic option in the treatment of in-hospital erysipelas.
    Pereira De Godoy JM; Ribeiro A; Cozzetto De Oliveira AL; Batigalia F
    G Ital Dermatol Venereol; 2014 Feb; 149(1):150-1. PubMed ID: 24566577
    [No Abstract]   [Full Text] [Related]  

  • 13. [Erysipelas of the leg in hospital environment in Lome (Togo)].
    Pitche P; Tchangaï-Walla K
    Bull Soc Pathol Exot; 1997; 90(3):189-91. PubMed ID: 9410258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erysipelas at the dermatological clinic in Mannheim 1960-1975].
    Bertsch O; Bojanovsky A; Jung EG
    Z Hautkr; 1977 Sep; 52(17):885-9. PubMed ID: 910535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland.
    Łyko M; Kaczmarek M; Nekrasova P; Hryncewicz-Gwóźdź A; Maj J; Jankowska-Konsur A
    Adv Clin Exp Med; 2021 Sep; 30(9):981-985. PubMed ID: 34410045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
    Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
    Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatology in Germany.
    Barth J
    J Dermatol; 1998 Dec; 25(12):819-20. PubMed ID: 9990776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with a reduced response in the treatment of erysipelas.
    Linke M; Booken N
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):217-25. PubMed ID: 25706926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Empirical antibiotic therapy of complicated skin and soft tissue infections in dermatological practice].
    Magyar A; Garaczi E; Hajdú E; Kemény L
    Orv Hetil; 2011 Feb; 152(7):252-8. PubMed ID: 21296734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacterial dermohypodermitis and necrotizing fascitis: 104-case series from Togo].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Boukari T; Pitché P; Tchangaï-Walla K
    Med Trop (Mars); 2011 Apr; 71(2):162-4. PubMed ID: 21695874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.